Monday, September 14, 2026

Rocket Doctor Expands In-Network Access for More Than 100,000 Additional Eligible Members in New York

By

Published

5 min read

This growth aligns with Rocket Doctor’s approach to broadening patient access to reimbursed care through existing insurance networks.

New agreement enables eligible Medicare and commercial health plan enrollees of a prominent national insurer in New York State to receive virtual care led by physicians.

Rocket Doctor AI Inc. (CSE:AIDR)

This agreement represents another important milestone in our strategy to expand reimbursed access to physician-led care”— Dr. William Cherniak, Co-Founder and CEO of Rocket DoctorVANCOUVER, BRITISH COLUMBIA, CANADA, August 11, 2026 /EINPresswire.com/ — Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) announced today that physicians utilizing the digital health platform and marketplace operated by its wholly owned subsidiary, Rocket Doctor Inc., have finalized a new arrangement that enhances in-network availability of physician-directed virtual care for qualified health plan participants in New York.

As a newly designated B2i Digital Featured Company, a complete company profile will be published shortly at https://b2idigital.com/featured-companies

Through this agreement, Rocket Doctor will become accessible to over 100,000 eligible covered lives within participating individual Medicare Advantage PPO (Preferred Provider Organization) and Commercial health plans across the New York City metropolitan region, as well as selected upstate counties.

These figures do not account for the millions of members covered via administrative services only (ASO) or self-insured plans. Furthermore, the payer is part of a national reciprocal network initiative, which allows eligible members from other states to use Rocket Doctor’s in-network physicians when traveling within New York.

With this most recent agreement, Rocket Doctor now has access to roughly 10 million covered lives throughout New York and approximately 24 million covered lives across the United States, leveraging its expanding roster of commercial and public payer partnerships to support the Company’s goal of scaling reimbursed, physician-led care. The agreement, finalized on July 15, 2026, carries an initial one-year duration, with automatic one-year renewals unless either party terminates or declines renewal as per its provisions.

Rocket Doctor’s initiatives allow patients to connect with licensed physicians from their homes for services such as urgent care, chronic disease management, preventive health, pediatrics, and mental health support. Through in-network participation, qualified members can obtain these services using their current insurance coverage, which may lower out-of-pocket expenses and enhance care convenience.

“This agreement represents another important milestone in our strategy to expand reimbursed access to physician-led care,” said Dr. William Cherniak, Co-Founder and CEO of Rocket Doctor. “By increasing the number of patients who can connect with physicians through their existing health benefits, we are helping reduce financial barriers to care while building a more sustainable model for delivering high-quality virtual care at scale.”

By broadening its involvement across Medicare Advantage and commercial health plans, Rocket Doctor is simplifying access to physician care for eligible patients through their existing coverage, while also generating new prospects for recurring reimbursement and sustained growth.

About Rocket Doctor AI Inc.

Rocket Doctor AI Inc. provides physician-designed, AI-driven solutions aimed at making high-quality healthcare accessible throughout the entire patient journey. A key component of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with contributions from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc, along with its AI-powered digital health platform and marketplace. Having supported over 350 MDs in delivering care across more than 750,000 patient visits, our proprietary technology software and systems enable doctors to independently start and run their own virtual or hybrid in-person practices – boosting efficiency, restoring autonomy to physicians, and widening patient access to care.

By lessening administrative workloads and promoting greater care consistency, our technology frees up more time for meaningful physician-patient interactions. We are dedicated to reaching underserved, rural, and remote communities in Canada that often lack family doctors, and to supporting patients on Medicaid and Medicare in the United States. Through advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare – making it more scalable, equitable, and patient-centered.

To learn more about Rocket Doctor AI Inc’s products and services, contact:

www.rocketdoctor.ai or email: info@rocketdoctor.ai

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai

Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io

For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321

Cautionary Statements

This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Company’s expansion of in-network access for eligible health plan members in New York and the anticipated benefits thereof, the Company’s ability to grow its network of covered lives across New York and the United States, the expected benefits of the new agreement with participating Medicare Advantage and commercial health plans, the Company’s continued growth across North America, the ability of the Company to attract and retain commercial and public payer relationships, the anticipated recurring reimbursement opportunities and long-term growth resulting from expanded in-network participation, and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.’s expectations include the risk that the new agreement may not generate the anticipated number of eligible patient visits or reimbursement revenue, risks relating to the termination or non-renewal of the agreement by either party in accordance with its terms, risks relating to changes in health plan membership, benefit coverage, or eligibility criteria, risks relating to cybersecurity and data privacy regulation in Canada and the United States, and other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

Additional Contact:

David Shapiro
B2i Digital, Inc.
+1 212-579-4844
david@b2idigital.com
Visit us on social media:
LinkedIn
Bluesky
Instagram
Facebook
YouTube
TikTok
X
Other

Rocket Doctor AI (CSE: AIDR) expands in-network access to physician-led virtual care


David Hall

David Hall

David is the senior editor at FintechNewsWatch. He has a background in journalism and has worked with various media outlets, covering topics ranging from digital banking and blockchain technology to startup funding and regulatory developments. When he is not writing, David enjoys reading, hiking, photography, and exploring new coffee shops.